INS and type 1 diabetes mellitus: For example, improved models for exercise would help train algorithms on proper dosing strategies during and after exercise, and novel uses of insulin analogs along with non-insulin adjunctive therapies significantly alter glucose-insulin dynamics in T1DM patients [32–34].